PARKINSUN communication aid to support patient-centered Parkinson's care
Official title: Optimizing PD Patient's Health Pathways: Favoring Global, Patient Centered Care by a New Communication Aid Tool PARKINSUN
Run by University Hospital, Lille · NCT04179695 · Data updated 2026-11-12
This project will test whether using the PARKINSUN communication tool during GP and neurologist visits helps people with Parkinson's disease get more patient-centered care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | July 21, 2020 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT04179695 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson's disease of any stage who can attend regular GP or neurology visits, speak French, are cognitively intact (MoCA >22), and can give informed consent are ideal candidates.
✕Probably not a fit
People with significant cognitive impairment, major psychiatric or neurological comorbidities, those under legal guardianship, unable to attend visits, or not fluent in French are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PARKINSUN is a brief communication aid intended to structure conversations between people with Parkinson's and their physicians. In this randomized intervention, adult patients with PD are assigned to bring and use PARKINSUN during routine consultations or to continue usual consultations without the tool. Visits occur every three months over a seven-month period and comparisons focus on measures of communication quality and care coordination. Participants must be able to attend in-person visits and meet basic cognitive and language criteria for participation.
Why it matters
Potential benefit: If successful, PARKINSUN could improve patient–physician communication and lead to more personalized and coordinated care for people with Parkinson's disease.
How similar studies have gone: Communication aids have produced benefits in other chronic conditions, but evidence specifically demonstrating impact in Parkinson's disease is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult men and women with all stages of PD * Without severe chronic neurological or mental or psychiatric pathology * Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22) * able to come (alone or accompanied) to consultation * Affiliate or beneficiary of a social security scheme * Subject having signed informed consent * Patient willing to comply with all procedures of the study and its duration Exclusion Criteria: * Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent. * Subject under tutelage or curtailer. * Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
Where it's running
-
Hopital Roger Salengro, CHU Lille
Lille, France Recruiting
Study contacts
- Principal investigator: David Devos — University Hospital, Lille
- Study coordinator: David Devos, MD,PhD
- Email: david.devos@chru-lille.fr
- Phone: 03 20 44 54 49
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Real-world experiences of Inbrija for Parkinson's OFF episodes
This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Test of RO7568282 in early Parkinson's disease
This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.